Teenage boy revels in ‘freedom’ after £1.65 million gene-editing treatment - Adam Rehman underwent treatment after previously relying on monthly blood transfusions ...
Claude AI now connects with Apple Health, letting users talk through their fitness and health data to spot trends, understand metrics, and get plain-language insights instead of raw numbers. The post ...
A deep learning framework combines convolutional and bidirectional recurrent networks to improve protein function prediction from genomic sequences. By automating feature extraction and capturing long ...
On Monday, Tencent’s AI assistant Yuanbao rolled out a new social feature, Yuanbao Groups (元宝派), in beta testing, aiming to ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for ...
Chart Industries supplies engineered equipment for energy and industrial gas markets, including LNG, hydrogen, and carbon capture solutions.
ECINET, ECI's new digital platform, unifies over 40 election services, enhancing transparency and efficiency in Indian ...
Macrolides are an important class of antibiotics that includes drugs such as azithromycin and erythromycin, which are widely ...
Camo developer Reincubate is suing Apple over Continuity Camera, accusing Apple of patent infringement and deceit surrounding ...
From bulldozers and viral posts to bureaucratic deadlock and street protests, Balendra Shah’s mayoral record reveals the promise—and limits—of disruption politics in Nepal.
Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results